Keyword Index

A

  • Anticancer Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
  • Autoimmune A potential therapy for the Rheumatoid Arthritis: New drug discovery [Volume 2, Issue 1, 2023, Pages 11-20]

B

  • Biologics A potential therapy for the Rheumatoid Arthritis: New drug discovery [Volume 2, Issue 1, 2023, Pages 11-20]

C

  • Citrullination A potential therapy for the Rheumatoid Arthritis: New drug discovery [Volume 2, Issue 1, 2023, Pages 11-20]
  • Corona virus Review article on instrumental analysis of Molnupiravir, Favipiravir, and Ritonavir in different matrices [Volume 2, Issue 1, 2023, Pages 36-43]

F

  • Favipiravir Review article on instrumental analysis of Molnupiravir, Favipiravir, and Ritonavir in different matrices [Volume 2, Issue 1, 2023, Pages 36-43]

H

  • Heck Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]

K

  • Key Words: HPLC Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]

M

  • MMP-1 Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]
  • MMR Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
  • Molnupiravir Review article on instrumental analysis of Molnupiravir, Favipiravir, and Ritonavir in different matrices [Volume 2, Issue 1, 2023, Pages 36-43]

P

  • Pioglitazone Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]

R

  • Rescinnamine Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers [Volume 2, Issue 1, 2023, Pages 21-35]
  • Rheumatoid Arthritis A potential therapy for the Rheumatoid Arthritis: New drug discovery [Volume 2, Issue 1, 2023, Pages 11-20]
  • Ritonavir Review article on instrumental analysis of Molnupiravir, Favipiravir, and Ritonavir in different matrices [Volume 2, Issue 1, 2023, Pages 36-43]

S

  • Stability tests Determination of alogliptin benzoate and pioglitazone hydrochloride in their dosage forms, validation and stability-indicating studies using RP-HPLC method. [Volume 2, Issue 1, 2023, Pages 1-10]

T

  • TACE Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) [Volume 2, Issue 1, 2023, Pages 44-62]